Ashvattha Therapeutics (Series B Extension)
Funding Details
Awarder
Inbox
Date Award
January 13, 2025
Vertical
Nanomedicine
Funding URL
View Funding Page
Funding Amount
$50,000,000
Company Info
Traction
Funding will enable completion of ongoing Phase 2 ophthalmology trial and Phase 1/2 neuroinflammation trial.
Market
Ophthalmology and Neuroinflammation
Location
Redwood City, California, USA
Coinvestors
Tribe Capital, Natural Capital
Company Description

Ashvattha Therapeutics is a clinical-stage company advancing a new class of nanomedicine therapeutics that traverse tissue barriers to selectively target and reprogram activated cells in regions of inflammation.

Links
Website
Back to HomeBack to Nanomedicine DealsView Funding Announcement